U2Bio maximizes shareholder profits and corporate value based on a stable and long-term growth strategy.
HomeInvestment InformationFinancial Information
- Financial Information
- Financial Information Corporate Disclosure Investment Inquiries Announcement to Shareholders
KRX as of 2023.03.285040
|Compared to the previous day||Fluctuation rate||Volume (stocks)|
|Open price(KRW)||High price(KRW)||Low price(KRW)|